Sabby Management, LLC Bio Path Holdings Inc Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.13 - $7.63 $368,949 - $548,749	-71,920 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$3.63 - $11.77 $261,069 - $846,498	71,920 New	71,920 $505,000
Q3 2020 Nov 16, 2020	SELL	$3.85 - $5.5 $173,250 - $247,500	-45,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$4.15 - $6.04 $453,553 - $660,111	-109,290 Reduced 70.83%	45,000 $227,000
Q1 2020 May 15, 2020	BUY	$3.07 - $8.26 $94,998 - $255,597	30,944 Added 25.09%	154,290 $694,000
Q4 2019 Feb 14, 2020	BUY	$6.97 - $12.3 $859,721 - $1.52 Million	123,346 New	123,346 $986,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $6.37M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.